Thomas Kosten, MD

Thomas Kosten, MD

Neurology Houston, TX

Professor, Psychiatry, Baylor College of Medicine


Office Address

  • 2002 Holcombe Blvd
    Va Bldg 110, Room 229
    Houston, TX 77030
    Phone: (713) 794-7032

Thomas Kosten, MD

Neurology Houston, TX

Professor, Psychiatry, Baylor College of Medicine

Clinical Specialties & Interests

  • Neurology: Addiction Medicine

Education & Training

  • Yale-New Haven HospitalYale-New Haven Hospital
  • Yale University School of MedicineYale University School of Medicine
  • Yale-New Haven HospitalYale-New Haven Hospital
  • Weill Cornell Medical College of Cornell UniversityWeill Cornell Medical College of Cornell University

Certifications & Licensure

  • TX State Medical LicenseTX State Medical License2007 - 2016
  • CT State Medical LicenseCT State Medical License1979 - 2016
  • American Board of Psychiatry and NeurologyPsychiatry

    Awards, Honors, & Recognition

    • Whos Who in Medicine and HealthcareMarquis Whos Who

    Clinical Trials

    Publications & Presentations

    PubMed

    Grant Support

    • Human Methamphetamine Vaccine: Translational Avante Garde AwardNational Institute On Drug Abuse
      2011 - 2011
    • Methadone StudiesNational Institute On Drug Abuse
      2009 - 2011
    • Stimulant Pharmacotherapy: Noradrenergic TargetsNational Institute On Drug Abuse
      2009 - 2011
    • Developing Immunotherapeutics For Methamphetamine AbuseNational Institute On Drug Abuse
      2009 - 2010
    • Clinical Methods CoreNational Institute On Drug Abuse
      2009 - 2011
    • Multisite Controlled Trial Of Cocaine Vaccine (1of 6) LEAD Site/ Houston TreatmenNational Institute On Drug Abuse
      2008 - 2012
    • Pharmacotherapies Of Cocaine Addiction In HumansNational Institute On Drug Abuse
      2007 - 2007
    • Administrative And Scientific CoreNational Institute On Drug Abuse
      2007 - 2008
    • Tropisetron With Risperidone For SchizophreniaNational Institute Of Mental Health
      2007 - 2009
    • Cocaine Pharmacotherapy Targeting Dopamine &GabaNational Institute On Drug Abuse
      2006 - 2008
    • Comorbidity In Cocaine And Opioid PharmacotherapyNational Institute On Drug Abuse
      2006 - 2010
    • Heroin Addiction Treatment: Naltrexone And LofexidineNational Institute On Drug Abuse
      2006 - 2007
    • Comorbidity In Cocaine And Opioid PharmacotherapyNational Institute On Drug Abuse
      2005 - 2005
    • Kappa Opioid Antagonist For Cocaine AddictionNational Institute On Drug Abuse
      2005 - 2011
    • Heroin Addiction Treatment: Naltrexone And LofexidineNational Institute On Drug Abuse
      2004 - 2005
    • Cocaine Pharmacotherapy Targeting Dopamine &GabaNational Institute On Drug Abuse
      2004 - 2005
    • Scientific And Administrative CoreNational Institute On Drug Abuse
      2004 - 2004
    • FMRI Of Gender And Stress Response In Cocaine DependenceNational Institute On Drug Abuse
      2002 - 2002
    • Cocaine Vaccine For Methadone Maintained PatientsNational Institute On Drug Abuse
      2002 - 2004
    • Pharmacotherapy For Opioid And Cocaine DependenceNational Institute On Drug Abuse
      2001 - 2004
    • Immunological Agents For Cocaine AbuseNational Institute On Drug Abuse
      2000 - 2002
    • Comorbidity In Cocaine And Opioid PharmacotherapyNational Institute On Drug Abuse
      2000 - 2004
    • Active Immunization To Develop Antibodies To CocaineNational Institute On Drug Abuse
      2000 - 2002
    • 11th - 15th Annual Meetings And SymposiaNational Institute On Drug Abuse
      2000 - 2001
    • Therapeutic Cocaine VaccineNational Institute On Drug Abuse
      2000 - 2002
    • Core--Medication Development Research CenterNational Institute On Drug Abuse
      1999 - 2002
    • Clopidogrel &Isradipine For Brian Perfusion Defects In Cocaine AbusersNational Institute On Drug Abuse
      1999 - 2002
    • Cocaine Pharmacotherapies For Comorbid PopulationsNational Institute On Drug Abuse
      1999 - 2003
    • 9th/13th Annual Meeting And SymposiumNational Institute On Drug Abuse
      1998 - 1999
    • Immunological Agents For Cocaine AbuseNational Institute On Drug Abuse
      1997 - 1998
    • Active Immunization To Develop Antibodies To CocaineNational Institute On Drug Abuse
      1997 - 1998
    • Cocaine Discrimination In Humans--Effects Of Dopaminergic AgentsNational Institute On Drug Abuse
      1996 - 1997
    • Non-Opioid Neurobiology Of Opioid DependenceNational Institute On Drug Abuse
      1996 - 1997
    • Core--CoreNational Institute On Drug Abuse
      1996 - 1998
    • Agonist To Antagonist--New ApproachesNational Institute On Drug Abuse
      1994 - 1995
    • Reducing AIDS RisksNational Institute On Drug Abuse
      1994 - 1994
    • Yale Medications Development Research CenterNational Institute On Drug Abuse
      1994 - 1998
    • Small Instrumentation GrantNational Institute On Drug Abuse
      1993 - 1993
    • Matching Methadone Patients To Psychosocial TreatmentNational Institute On Drug Abuse
      1993 - 1994
    • The Yale University Substance Abuse Research CenterNational Institute On Drug Abuse
      1991 - 1991
    • Clinical Research Center For Opioid And Cocaine AbuseNational Institute On Drug Abuse
      1991 - 1999
    • Treatment Research Unit--Reducing AIDS RisksNational Institute On Drug Abuse
      1989 - 1993
    • Buprenorphine Maintenance For Opioid AddictsNational Institute On Drug Abuse
      1988 - 2000
    • Agonist To Antagonist: New ApproachesNational Institute On Drug Abuse
      1987 - 1993
    • Pharmacotherapy Of IV Cocaine Use In Methadone PatientsNational Institute On Drug Abuse
      1987 - 1989

    Professional Memberships

    • The full profile is locked and available to verified physicians only.
      Join over 50% of U.S. physicians already on Doximity and get access to this and over 700,000 physician CVs. Find your physician profile

    Physicians, view Dr. Kosten's full Doximity profile to:

    • Trade HIPAA-secure messages
    • Send and receive online faxes
    • Refer a patient
    • See their complete CV